. In addition, autoradiographic evidence indicates that the Iype II cell is the progenitor cell for the Type I epithelium in the developing lung (3) .
Although Type II cell function is of fundamental importance to the well-being of the organism, very little is known about the pathobiology of the Type II cell. Very few studies have examined Lype II cell function under conditions of naturally occurring or chemically induced lung disease. Perturbations of the surfactant system accompany a number of human respiratory conditions, including the neonatal and adult respiratory distress syndromes (4, 5) , idiopathic pulmonary fibrosis (6) , and alveolar proteinosis (7, 8) , but the causes of the surfactant abnormalities and their relationship to the progression of disease have not been delineated. In addition, in experimental animals, alterations in surfactant levels have been reported following exposure of the lung to a variety of chemical and physical agents, suggesting that Type II cells and the surfactant system may be important components in the response ofthe lung to irnury.
Our laboratoryisinterested inthe mechanisms through which toxic agents influence the pulmonary surfactant system. Of the many agents reported to affect the surfactant system, perhaps the most potent is silica. The increases in surfactant that occur in response to silica deposition in the lung have been well documented (9) (10) (11) (12) , and recently we have extended those studies to the cellular level in an attempt to understand the underlying mechanisms through which silica is acting.
In this review we will discuss our recent findings concerning the effects of pulmonary toxicants on the Type II cell population. Our major focus will be the changes in Type II cells caused by silica and how those changes may account for the increased levels of surfactant phospholipids found in the lungs of silica-exposed rats. However, we emphasize that, while the response of the surfactant system to silica has been the most wellstudied example of surfactant changes in chemicalinduced lung injury, it is probable that many other compounds could act through similar mechanisms.
The Type 11 Cell
The alveolar epithelium of the lung (Fig. 1 ) is composed primarily of two cell types, Type I and Type II cells. Type I cells account for approximately 97% of the surface area of the alveolar epithelium (13) . These squamous cells provide a large surface area, allowing for the efficient exchange of gases between the alveolar space and the vascular compartment. Type II cells are cuboidal cells, and although they occupy only about 3% of the alveolar surface in the rat lung, they constitute approximately 63% of the total alveolar epithelial cells (13, 14) . Type II cells are typically found in corners or niches of alveolar septa and are characterized by surface microvilli and abundant mitochondria and rough endoplasmic reticulum. The most distinctive ultrastructural feature of the Type II cell is the cytoplasmic lamellar inclusion body, the intracellular storage site of pulmonary surfactant ( Fig. 1) (20, 21) .
Evaluation of Type II cell hyperplasia typically has been based on qualitative histological examinations by light microscopy. For quantitative determination of the TMype II cell proliferative response, electron microscopic, morphometric analysis has been the usual approach (22) . This methodology has been used to examine the cellular changes occurring in the lung parenchyma in response to oxygen (14, 23) and asbestos (24, 25) . However, electron microscopic morphometric techniques are lengthy, tedious, and expensive; thus they are not suitable for routine use.
Light microscopy has been used to study Type II cell population kinetics. The usual approach has been to label proliferating cells with 3H-thymidine, followed by determination of the labeling index, i.e., the proportion of the total cells incorporating 3H-thymidine. For example, Adamson and Bowden (26) used the labeling index to determine that Type II cell proliferation was maximal 2 to 3 days after intratrachael instillation of silica into the lungs of mice. These same authors (27) showed that exposure to short crocidolite asbestos fibers (mean length of 24 ,um), on the other hand, produced only a slight degree of lype II cell hyperplasia (28) . The labeling index method has also been used to study Type II cell proliferation in lung irnury induced by oxygen (29) , cadmium (30) , butylated hydroxytoluene (31) , and nitrogen dioxide (32) . In all of these studies, it was found that the proliferative burst of the Type II cell population occurred within several days of the beginning of the exposure.
Although the labeling index approach has been useful, it suffers from two major disadvantages. First, the pro- (24, 25) . The intravenous administration of Freund's adjuvant to rabbits resulted in Type II cells that contained larger and more numerous lamellar bodies (39) . Likewise, the lungs of rats exposed to cigarette smoke for 25 days contained hypertrophic lype II cells with increased numbers of lamellar bodies (40) .
In the silica-exposed lung, the ultrastructural changes that occurred in the lamellar body compartment of hypertrophic Type II cells were evaluated morphometrically, and it was found that these cells contained lamellar bodies that were, on the average, twice the volume of those found in normal Type II cells (Fig. 7 , Thble 1) (41). In addition, hypertrophic Type II cells contained approximately 40% more lamellar bodies per cell. In the case of silica, the hypertrophic response appears to be progressive in nature with the number of hypertrophic Type II cells increasing over time (42) . 
Pulmonary Surfactant
Pulmonary surfactant is absolutely essential for normal lung function. At end-expiration, when alveolar volume is minimal, surface tension forces would cause collapse of alveoli if surfactant were not present. An important biophysical property of surfactant is that upon compression, as occurs at end-expiration, its surface tension decreases to near zero. Thus, the presence of surfactant maintains alveolar stability at low lung volumes (45) .
In the lung, surfactant is located in two distinct, but interrelated, compartments. Extracellular surfactant refers to surfactant that is present in the lumen of the alveoli and distal airways. This surfactant compartment may be removed quantitatively from the lungs by using bronchoalveolar lavage (46 lowering ability of surfactant. In addition to its unique phospholipid composition, surfactant also contains several surfactant-specific proteins that are important in surfactant function (50) . A variety of compounds have been shown to affect surfactant levels in the lung. Increases in surfactant levels are a frequent finding in the lungs of toxicant-exposed animals. In the bleomycin-exposed lung, 'Iype II hypertrophy was associated with increases in extracellular surfactant phospholipids (36) . Exposure to oxidant gases also results in increases in surfactant-associated phospholipids. Increases in both the extracellular and intracellular pools of surfactant have been found following exposure to oxygen (51, 52) , ozone (38) , and nitrogen dioxide (53) . Inhalation of cadmium aerosol (54) and diesel exhaust (32) also resulted in increased extracellular surfactant.
Mineral dusts appear to be especially potent in promoting the accumulation of surfactant phospholipids. Increases in extracellular surfactant in response to asbestos deposition have been reported in several studies (55) (56) (57) . Crystalline silica (alpha-quartz) is perhaps the most powerful inducer of surfactant phospholipids. The effects of silica on surfactant phospholipids have been particularly well studied. Fallon (58) was the first to report that silica causes an increase in the phospholipid content of the lung, an observation that was incorrectly attributed to macrophage influx and disintegration. Heppleston and his colleagues (59) (60) (61) showed that the majority of the increases in phospholipids in silicaexposed lungs resulted from large increases in phosphatidylcholine and disaturated phosphatidylcholine, which they suspected arose from pulmonary surfactant. These workers believed that the silica-induced pulmonary phospholipidosis was similar to alveolar proteinosis, a disease of the human lung characterized by the accumulation of large amount of lipid (7). Gabor et al. (9) demonstrated that silica deposition in the lungs resulted in up to a 12-fold increase in extracellular surfactant phospholipids. Dethloff et al. (10) (11) (12) examined the effects of silica on surfactant-associated phospholipids in detail. These authors found that, along with increases in extracellular surfactant, silica had an even more dramatic effect on the intracellular pool of surfac-¶Nble 3. Intra-and extracellular surfactant-associated phospholipid composition in the lungs of control and silica-exposed rats. tant. Greater than 120-fold increases in the intracellular surfactant pool could be induced (10) . Despite these enormous increases, the phospholipid composition of the surfactant was similar to that in control lungs (Thble 3) . Approximately 85% of the increase in phospholipids in the lung caused by silica was associated with the surfactant system, indicating that the surfactant system is a specific target of silica (10) . An interesting finding in several of the studies mentioned above is that extracellular surfactant levels can remain elevated, even many weeks after exposure to mineral dusts. For example, Gabor et al. (9) found that extracellular surfactant levels remained elevated up to 26 weeks following exposure. Similarly, Richards and Curtis (62) found that the increases in extracellular surfactant produced by silica remained approximately five times higher than in control animals for as long as 48 weeks after exposure. Increases in surfactant following inhalation of chrysotile asbestos remained approximately 2.5-fold above control levels up to 50 weeks after exposure (57). Asbestos and silica are well known as etiologic agents in the development of pulmonary fibrosis. It is, therefore, conceivable that the increases in surfactant induced by these fibrogenic dusts are somehow related to the progression of the fibrotic process (62) . In this regard, it is noteworthy that nonfibrogenic dusts do not elicit a surfactant response (9, 62) .
It is apparent from the preceding discussion that an increase in surfactant levels is a common response to lung insult. It should also be noted, however, that increased surfactant levels are not a generalized response of the lungs to all toxic chemicals. Some compounds appear to cause a decrease in extracellular surfactant levels. For example, the volatile, organic compounds trichloroethylene, carbon tetrachloride, and gasoline all appear to cause decreases in extracellular surfactant (63, 64) .
Surfactant Biosynthesis in the Injured Lung
Although surfactant metabolism in the toxicantexposed lung has not been well studied, a number of investigators (65) (66) (67) have proposed that stimulation of biosynthesis is the underlying cause accounting for the accumulation of surfactant. Young et al. (51) found that, in the oxygen-exposed lung, production of surfactantassociated disaturated phosphatidylcholine was increased at least 4-fold. Richards and Lewis (67) (68) found that Type II cells isolated from the lungs of rabbits exposed to bleomycin had a 1.6-fold higher level of phosphatidylcholine biosynthesis. Type II cells isolated from the lungs of rabbits exposed to oxygen incorporated radiolabeled choline into phosphatidylcholine and disaturated phosphatidylcholine at a greater rate than Type II cells from unexposed rabbits (52) .
Wright et al. (69) reported that the activities of several enzymes involved in phospholipid biosynthesis were elevated in Type II cells isolated from the lungs of rats exposed to nitrogen dioxide. Type II cells isolated from the lungs of silica-treated rats also have an increased capacity for the production of surfactant-associated phospholipids (70 (70) .
In the silica-treated lung, activation of the CDP-choline pathway for the biosynthesis of phosphatidylcholine appears to be the mechanism accounting for the increased production of phosphatidylcholine and disaturated phosphatidylcholine by hypertrophic Type II cells.
Increased activities of the two terminal enzymes of the CDP-choline pathway, cholinephosphate cytidylyltrans-ferase (EC 2.7.7.15) and cholinephosphotransferase (EC 2.7.8.2), were found in the hypertrophic Type II cells (Miller and Hook, unpublished observations). Further, the increase in the activity of cholinephosphate cytidylyltransferase was shown to result from an increase in the activity of the membrane-bound and not the soluble form of the enzyme. The physiologically active form of the enzyme appears to be the membrane-bound form (71) .
In addition to increased biosynthesis of surfactantassociated phospholipids, the biosynthesis is the major In most of the examples of increased surfactant levels discussed above, Type II cell hyperplasia alone cannot seem to account for the increase. In the case of silica, during a period when Type II cell numbers in the lungs increased only 2-fold, intracellular pools of surfactant phospholipids increased 20-fold (33, 66) . There seems little doubt that the increased levels of surfactant seen in the lungs of silica-exposed rats is due to the presence of hypertrophic T5ype II cells. Within the hypertrophic TIype II cells, increased levels of surfactant phospholipids appear to be brought about through activation of biosynthetic pathways. In fact, the hypertrophic state of the cells may arise from enhanced biosynthesis of surfactant phospholipids.
An important question that must still be addressed is what does the Type II cell activation and the accumulation of surfactant mean in terms of pulmonary function? Do increased levels of surfactant serve to somehow protect the lungs, as suggested by the results of several studies (62, 73) ? The activation of Type II cells and the significance of the surfactant increases is an area which has received very little attention, but in view of the apparent generalized nature of the hypertrophic response, an important physiological function of the surfactant system may yet await discovery.
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